Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Stomach”

1,011 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,011 results

Testing effectiveness (Phase 2)UnknownNCT02177552
What this trial is testing

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
Rigshospitalet, Denmark 98
Testing effectiveness (Phase 2)UnknownNCT04367025
What this trial is testing

Efficacy and Safety of Perioperative Chemotherapy Plus PD-1 Antibody in Gastric Cancer

Who this might be right for
Gastric Cancer
Chinese PLA General Hospital 70
Early research (Phase 1)Active Not RecruitingNCT05891171
What this trial is testing

Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers

Who this might be right for
Advanced CancerAdvanced MalignanciesBladder Cancer+9 more
Arcus Biosciences, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00017043
What this trial is testing

BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy

Who this might be right for
Esophageal CancerGastric Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07266025
What this trial is testing

Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study

Who this might be right for
Gastric AdenocarcinomaGastroesophageal AdenocarcinomaMismatch Repair Deficient or MSI-High Solid Tumors+1 more
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04603040
What this trial is testing

Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers

Who this might be right for
Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy
Shanghai Junshi Bioscience Co., Ltd. 100
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Not applicableStudy completedNCT04920747
What this trial is testing

Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients

Who this might be right for
HER2-positive Gastric CancerMetastatic CancerDocetaxel+1 more
Centre Hospitalier Universitaire de Besancon 65
Early research (Phase 1)Study completedNCT06056024
What this trial is testing

Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Who this might be right for
Solid Tumor, KRAS Mutation
Boehringer Ingelheim 47
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Testing effectiveness (Phase 2)Ended earlyNCT05555251
What this trial is testing

BI-1607 in Combination with Trastuzumab in Subjects with HER2-positive Advanced Solid Tumors

Who this might be right for
HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Metastatic Breast Cancer+2 more
BioInvent International AB 18
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362186
What this trial is testing

LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Limited 400
Not applicableStudy completedNCT04161781
What this trial is testing

PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Who this might be right for
Esophagogastric CancerEsophagus CancerEsophageal Cancer+4 more
Memorial Sloan Kettering Cancer Center 10
Large-scale testing (Phase 3)UnknownNCT05919381
What this trial is testing

Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.

Who this might be right for
Adenocarcinoma of Stomach
Changchun GeneScience Pharmaceutical Co., Ltd. 752
Testing effectiveness (Phase 2)Study completedNCT02301481
What this trial is testing

Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma

Who this might be right for
Stomach NeoplasmsNeoadjuvant TherapyChemoradiotherapy+1 more
Chinese Academy of Medical Sciences 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06118645
What this trial is testing

Cadonilimab+ Paclitaxel (Albumin-bound) Treat Advanced Gastric Adenocarcinoma With PD-(L)1 Inhibitors Resistance

Who this might be right for
Gastric Adenocarcinoma
China Medical University, China 40
Testing effectiveness (Phase 2)Looking for participantsNCT06985602
What this trial is testing

Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ

Who this might be right for
Gastroesophageal AdenocarcinomaGastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital 30
Early research (Phase 1)Study completedNCT00113581
What this trial is testing

Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Merck KGaA, Darmstadt, Germany 26
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Large-scale testing (Phase 3)Study completedNCT05008783
What this trial is testing

AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Akeso 610
Load More Results